您现在的位置: 首页> 研究主题> 心肌病,充血性

心肌病,充血性

心肌病,充血性的相关文献在1999年到2015年内共计139篇,主要集中在内科学、基础医学、临床医学 等领域,其中期刊论文139篇、专利文献6804篇;相关期刊51种,包括中国病理生理杂志、中华超声影像学杂志、中华地方病学杂志等; 心肌病,充血性的相关文献由533位作者贡献,包括刘凤岐、张瑶、杨英珍等。

心肌病,充血性—发文量

期刊论文>

论文:139 占比:2.00%

专利文献>

论文:6804 占比:98.00%

总计:6943篇

心肌病,充血性—发文趋势图

心肌病,充血性

-研究学者

  • 刘凤岐
  • 张瑶
  • 杨英珍
  • 陈灏珠
  • 于波
  • 常青
  • 杨好意
  • 池洪杰
  • 赵世华
  • 邓又斌
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 邵科晶; 李库林; 肖翼春; 陈飞; 朱宝
    • 摘要: 目的:分析扩张型心肌病(DCM)患者左室各壁心肌99Tcm⁃MIBI摄取情况,探讨其与左室同步性的关系。方法选取43例初次确诊为DCM的患者[男30例,女13例,年龄(50.58±13.29)岁],以QRS波时限作为左室收缩同步性分组标准对患者进行分组:QRS正常( QRS波时限<120 ms)的24例作为同步组,QRS增宽( QRS波时限≥120 ms)的19例作为不同步组。分析患者99 Tcm⁃MIBI静息门控MPI结果,应用定量门控心肌灌注显像( QPS)软件计算得到2组LVEF、PFR、ESV、EDV等心功能参数,并计算受检者左室心尖、前壁、侧壁、下壁及间隔的99 Tcm⁃MIBI摄取百分数、摄取减低程度及范围。应用IBM SPSS 21.0软件进行独立样本t检验和Mann⁃Whitney u检验。结果同步组和不同步组LVEF分别为(26.44±5.59)%和(23.70±5.27)%(t=1.240,P>0.05),其余3个心功能参数在2组间的差异也均无统计学意义( t:0.195、0.113、0.291,均P>0.05)。2组5个节段的99 Tcm⁃MIBI摄取百分数差异均无统计学意义(t:-0.712~1.059,均P>0.05)。不同步组下壁摄取减低程度(0.6~3.3 s)、范围(0~65%)均较同步组相应值(0.1~2.5 s,0~36%)明显增高(z:-2.266、-2.391,均P<0.05)。结论99 Tcm⁃MIBI心肌摄取分析可以显示DCM患者心肌受损部位、程度及范围;左室下壁99 Tcm⁃MIBI摄取减低程度及范围对DCM患者左室同步性存在显著影响。%Objective To analyze the relationship between left ventricular myocardial 99 Tcm⁃MIBI uptake and the left ventricular synchronization in patients with dilated cardiomyopathy ( DCM) . Methods Forty⁃three cases (30 males and 13 females, age (50.58±13.29) years) with DCM who underwent 12⁃lead electrocardiogram and rest gated MPI were included. Among them, 24 cases with QRS duration 0.05). The other three cardiac function parameters had no significant differences between the two groups ( t: 0. 195, 0113, 0.291, all P>0.05) . There were no significant differences of myocardial 99 Tcm⁃MIBI uptake between two groups in all segments of apex, anterior, lateral, inferior and septum wall ( t: -0.712-1.059, all P>005). Deeper severities (0.6-3.3 s) and wider abnormal extents (0-65%) of myocardial 99Tcm⁃MIBI up⁃take were found only in the area of inferior wall in synchronous group, compared to those in dyssynchronous group (0.1-2.5 s, 0-36%; z=-2.266, -2.391, both P<0.05). Conclusions Myocardial injury (loca⁃tion, severity and extent)in patients with DCM could be detected by myocardial 99Tcm⁃MIBI imaging. The se⁃verity and extent of myocardial injury may have a significant impact on the left ventricular synchronization.
    • 马兴鸿; 汪蕾; 王文尧; 闫朝武; 唐熠达; 赵世华; 方纬
    • 摘要: 目的 通过99Tcm-MIBI心肌灌注SPECT/18F-FDG心肌代谢PET显像和心脏MRI延迟增强成像(cMRI-LGE),探讨特发性扩张型心肌病(IDC)合并甲状腺功能减退(简称甲减)与心肌损伤的关系.方法 2010年10月至2012年12月诊断为IDC的连续病例63例[男42例,女21例,平均年龄(52±11)岁]入选,患者均进行血浆TT3、TT4、FT3、FT4和TSH全自动化学发光免疫法测定、99Tcm-MIBI心肌灌注SPECT/18F-FDG心肌代谢PET显像和cMRI-LGE.利用标准17节段模型进行心肌节段分析,灌注/代谢图像分成4种类型:正常灌注/代谢、灌注/代谢不匹配、灌注/代谢轻中度匹配、灌注/代谢完全匹配;cMRI-LGE图像分为无延迟强化、壁间强化和透壁强化.通过x2检验进行分组数据的比较.结果 根据所测血浆激素水平,患者被分成甲状腺功能(简称甲功)正常组(53例)和甲减组(10例).甲功正常组正常灌注/代谢的心肌节段数所占的比例明显高于甲减组:71.8%(647/901)和57.6% (98/170),x2=13.50,P<0.001;而灌注/代谢不匹配的心肌节段比例则低于甲减组:17.8%(160/901)和31.2% (53/170),x2=16.20,P<0.001.甲功正常组cMRI-LGE无延迟强化的心肌节段比例明显高于甲减组,分别为88.0% (793/901)和69.4% (118/170),x2=35.70,P<0.001;但壁间强化的心肌节段比例则低于甲减组,分别为4.8%(43/901)和24.1%(41/170),x2=74.70,P<0.001.结论 99Tcm-MIBI心肌灌注SPECT/18F-FDG心肌代谢PET显像和cMRI-LGE证实甲减能够加重IDC患者的心肌损伤.SPECT/PET可以检测出更多的慢性缺血/存活心肌,而cMRI-LGE可以检测出更多的心肌纤维化病变,两者结合能提供更全面的心肌损伤信息.%Objective To explore the relationship between hypothyroidism and myocardial injury in patients with idiopathic dilated cardiomyopathy (IDC) by 99Tcm-MIBI SPECT/18 F-FDG PET and late-gadolinium enhancement cardiac magnetic resonance imaging (cMRI-LGE).Methods Sixty-three consecutive patients (42 males and 21 females,(52±11) years) with IDC were enrolled from October 2010 to December 2012.Serum TT3,TT4,FT3,FT4 and TSH were determined using a fully automated chemiluminescence immunoassay.All patients underwent 99Tcm-MIBI myocardial perfusion SPECT/18F-FDG myocardial metabolism PET imaging and cMRI-LGE.Seventeen segments model was used for segmental analysis.Patterns of perfusion/metabolism were classified as normal,mismatch,mild-to-moderate match and complete match.cMRI-LGE was classified into 3 categories (non-LGE,mid-wall LGE and transmural LGE).x2 test was used for data analysis.Results All patients were divided into euthyroid group (n =53) and hypothyroidism group (n =10) according to the levels of serum thyroid hormones.The percentage of normal perfusion/metabolism segments in the euthyroid group was apparently higher than that in the hypothyroidism group:71.8% (647/901) vs 57.6% (98/170),x2 =13.50,P<0.001 ; whereas the percentage of perfusion/metabolism mismatch segments in the euthyroid group was significantly lower than that in the hypothyroidism group:17.8% (160/901) vs 31.2% (53/170),x2=16.20,P<0.001.The euthyroid group had a higher percentage of non-LGE segments (88.0% (793/901) vs 69.4% (118/170),x2 =35.70,P<0.001) and a lower percentage of mid-wall LGE segments (4.8 % (43/901) vs 24.1% (41 / 170),x2 =74.70,P< 0.001) compared to hypothyroidism group.Conclusions Hypothyroidism has a detrimental effect on myocardium.99Tcm-MIBI SPECT/18F-FDG PET imaging is sensitive in detecting viable/ischemia myocardium,and cMRI-LGE is good at detecting moderate fibrosis.Combining SPECT/PET imaging and cMRI-LGE for assessing myocardial injury would provide more comprehensive information.
    • 赵世华
    • 摘要: 应激性心肌病(SC)由应激事件触发而出现可逆性、特征性的左心室心尖球形扩张.最新的多中心、大样本、前瞻性研究结果表明应激性心肌病有着广泛的临床表现形式和多样性的左心室球形扩张形式.心血管MRI(CMR)不仅可以观察节段性室壁运动异常和量化心室功能,更重要的是能通过对比剂延迟强化(LGE)鉴别心肌可逆性(炎症、缺血性水肿)和不可逆性(坏死或纤维化)的损害.CMR的“一站式”成像对于反映应激性心肌病的基本病理生理学改变有独特的作用,有助于在急性临床表现发作时建立或者排除应激性心肌病的诊断.
    • 汪蕾; 方纬; 闫朝武; 杨敏福; 赵世华
    • 摘要: Objective To evaluate the relationship of myocardial MR contrast delay-enhancement and nuclear perfusion-metabolism pattern in patients with idiopathic dilated cardiomyopathy (IDCM).Methods Forty-two consecutive patients (29 men and 13 women,age:(53 ±12) years) diagnosed clinically with IDCM were enrolled.All patients underwent 99Tcm-MIBI SPECT,18F-FDG PET imaging and MR contrast delay-enhancement imaging within 3-7 d.The myocardial perfusion-metabolism segment analysis was performed using a 17-segment model.Segmental 99Tcm-MIBI and 18F-FDG uptakes were scored visually using a 4-grade scoring system (0 =normal uptake,1 =mildly reduced uptake,2 =moderately reduced uptake,3 =severely reduced uptake).Patterns of perfusiorn/metabolism were classified as normal,mismatch,mild-to-moderate match and severe match.Myocardial MR contrast delay-enhancement was classified into 3 categories (non,mid-wall and transmural delay-enhancement).x2 test was used to analyze the differences of perfusion/metabolism patterns among non,mid-wall and transmural delay-enhancement groups and the myocardial MR contrast delay-enhancement incidence among four perfusion/metabolism groups.Resuits Among the 42 patients,myocardial delay-enhancement was present in 18 patients,of which 94.4% (17/18) showed abnormal myocardial perfusion/metabolism patterns and only 33.3 % (8/24) patients without abnormal myocardial delay-enhancement had abnormal myocardial perfusion/metabolism patterns (x2 =15.944,P < 0.001).Perfusion/metabolism patterns varied in three different categories of non,mid-wall and transmural delay-enhancement (x2 =14.276,P < 0.001).The normal peffusion/metabolism pattern proportions in the non,mid-wall and transmural delay-enhancement groups were 86.2% (526/610),71.0% (44/62) and 28.6% (12/42),respectively.The incidence of transmural delay-enhancement (44.4% (12/27)) was significantly higher in segments with severe match than that in the other 3 groups (normal:2.1% (12/582) ; mismatch:18.1% (15/83) ; mild-to-moderate match:13.6% (3/22) ; x2 =112.530,P < 0.001).Conclusions MR contrast delay-enhancement is much more sensitive in detecting moderate fibrosis,while nuclear perfusion-metabolism imaging can detect more impaired but viable myocardium.Combining the two imaging modalities is useful for providing comprehensive evaluations of myocardial injury in patients with IDCM.%目的 比较99Tcm-MIBI SPECT/18F-FDG PET心肌灌注/代谢显像与心脏MRI延迟增强成像2种影像学方法评价特发性扩张型心肌病(IDCM)心肌损伤的特点.方法 对42例明确诊断为IDCM的连续患者[其中男29例,女13例,年龄(53±12)岁],行99Tcm-MIBI SPECT、18F-FDG心肌灌注/代谢显像和心脏MRI延迟成像,间隔时间为3~7d.利用17节段模型分别为各节段心肌灌注和代谢图像的放射性摄取评分,共分为4个等级:0=摄取正常,1=摄取轻度降低,2=摄取中度降低,3=摄取严重降低.根据心肌灌注/代谢匹配情况分为正常、不匹配、轻中度匹配、完全匹配4组;根据心脏MRI延迟成像结果分为无延迟强化、壁间强化、透壁强化3组,采用x2检验比较不同强化组间的灌注/代谢异常率差异和不同灌注/代谢匹配组间的延迟强化发生率.结果 全部42例患者中,18例心脏MRI延迟成像出现延迟强化,其中94.4% (17/18)患者心肌灌注/代谢异常;而另外24例心脏MRI延迟成像无延迟强化患者中,仅有33.3% (8/24)患者心肌灌注/代谢异常(x2=15.944,P<0.001).心肌节段分析中,无延迟强化、壁间强化、透壁强化3组相应的心肌灌注/代谢情况有差异,灌注/代谢正常率分别为86.2% (526/610)、71.0% (44/62)和28.6% (12/42)(x2=14.276,P<0.001).灌注/代谢不匹配组中75.9% (63/83)的心肌节段无延迟强化,而灌注/代谢完全匹配组透壁强化的发生率(44.4%,12/27)明显高于其他3组[正常组2.1%(12/582)、不匹配组18.1%(15/83)、轻中度匹配组13.6%(3/22),x2=112.530,P<0.001].结论 心脏MRI延迟成像检测轻度纤维化更敏感,而心肌灌注/代谢显像能够检测更多受损但存活的心肌.结合2种影像学方法评价IDCM患者心肌损伤可以提供更加全面的信息.
    • 于文彦
    • 摘要: 目的 观察芪苈强心胶囊联合渗附注射液对扩张型心肌病心力衰竭患者心功能的保护作用.方法 将96例扩张型心肌病心力衰竭患者分为3组,各32例.对照组给予心力衰竭的常规治疗;芪苈强心胶囊组在常规治疗基础上加用芪苈强心胶囊(每次4粒,每天3次);治疗组则在常规治疗基础上加用芪苈强心胶囊及每天静脉滴注参附注射液50 ml,疗程4周.观察3组治疗前后心功能变化、左室舒张末内径(LVIDd)、左室射血分数(LVEF)、6min步行距离及血浆脑利钠肽(BNP)等.结果 治疗4周后,治疗组患者心功能明显好转,血浆BNP水平及LVIDd较对照组低(P<0.01),LVEF高(P<0.01).3组均未见明显不良反应发生.结论 芪苈强心胶囊联合参附注射液可明显改善扩张型心肌病心功能不全患者的左室功能,提高运动耐量,安全性好.
    • 方玉; 王爱玲
    • 摘要: 1995年,ISFC/WHO将心肌病定义为伴心功能不全的心肌疾病,分为原发性和继发性两类.随着分子生物学、分子遗传学的发展和应用,有关心肌病的病因及发病机制的研究产生了许多重大的突破,因此,2006年AHA对心肌病给出了当代新的定义和分类,强调以基因和遗传为基础,将心肌病分为遗传性、混合性和继发性三大类[1].
    • 冉瑞明; 陈平; 史光东; 康忠明; 邓大河
    • 摘要: Objective To investigate the effects of ARB or/and β-blocker in treatment of dilated cardiomyopathy(DCM).Methods 95 cases with DCM were randomly divided into 3 groups.ARB group(A,32 cases) was treated with Irbesartan,150 mg/d without adverse drug reaction and then to 300 mg/d weekly; β-blocker group( B,30cases) was treated with Bisoprolol,1.25 mg/d without adverse drug reaction and then to maximal dose weekly; combination group( AB,33 cases) was treated with Irbesartan and Bisoprolol to maximal dose which patients were able to tolerate.The 3 groups were observed for a period of 12 months.Results Comparing with pretreatment,the results of 6min walk,LVEDd,LVESd,LVEF were improved significantly( all P <0.05).There were no significant differences between A group and B group(P >0.05),but the differences between combination group and A group or B group were significant( P <0.05 ).Conclusion Effect of ARB combined with β-blocker was better than that of ARB or β-blocker alone in treatment of DCM and well tolerated.%目的 观察血管紧张素受体拮抗剂(ARB)、β受体阻滞剂单用及联合应用对扩张型心肌病(DCM)的临床疗效.方法 将95例DCM患者随机分为ARB组(A组)32例,给予厄贝沙坦150 mg,1次/d,无不良反应,渐增量300 mg;β受体阻滞剂组(B组)30例,给予比索洛尔1.25 mg,1次/d,无不良反应,每1~2周剂量倍增至患者能耐受;ARB和β受体阻滞剂联合组(AB组)33例,以上两药联合应用至患者能耐受的最大剂量.三组均长期维持治疗,疗程12个月.结果 A、B、AB三组总有效率分别为84.37%、80.40%、93.93%,AB组与A、B组差异均有统计学意义(x2=4.95、3.95,均P<0.05),三组治疗后6 min步行距离、左室舒张末期内径(LVEDd)、左室收缩末期内径(LVESd)、左室射血分数(LVEF)与治疗前比较,差异均有统计学意义(均P<0.05),A组与B组差异无统计学意义(P>0.05),AB组与A组及B组差异均有统计学意义(均P<0.05).结论 ARB与β受体阻滞剂联合治疗DCM疗效优于单用ARB或β受体阻滞剂,且耐受好.
    • 蒋志新; 方纬; 闫朝武; 赵世华; 张健; 何作祥
    • 摘要: 目的 对原发性扩张型心肌病(IDCM)患者进行静息MPI和心脏磁共振延迟增强成像(DE-MRI)的对比分析,探讨2种诊断方法不同图像特征之间的对应关系.方法 40例确诊为IDCM的住院患者,均行99Tcm-MIBI静息MPI和DE-MRI,间隔不超过7 d.静息心肌灌注图像分为2种特征:弥漫性放射性减低和节段性放射性减低或缺损;DE-MRI分为4种类型:(1)无延迟强化;(2)壁间延迟强化;(3)内膜下延迟强化;(4)透壁性延迟强化.两样本率的比较采用x2检验.结果 在40例患者的静息MPI中,心肌放射性分布呈弥漫性减低19例(47.5%),呈节段性减低或缺损21例(52.5%);两者DE-MRI延迟强化的发生率分别为26.3%(5/19)与85.7%(18/21),差异有统计学意义(x2=14.401,P<0.001).对18例节段性放射性异常和延迟强化的患者按心肌节段分析,灌注正常、灌注减低与灌注缺失3组DE-MRI分型构成分别为112∶35∶2:5,98∶23∶7:1,13∶0∶5∶5,其中正常组与缺失组、减低组与缺失组之间差异有统计学意义(x2值为29.183与25.110,P均<0.001).结论 IDCM患者MPI既可以表现为典型的弥漫性放射性减低,也可表现为节段性放射性减低或缺损,后者DE-MRI出现延迟强化的比例较高.%Objective To compare 99Tcm-MIBI MPI with delayed enhancement MRI (DE-MRI) in patients with idiopathic dilated cardiomyopathy (IDCM). Methods Forty patients with IDCM were included. They underwent both rest 99Tcm-MIBI myocardial perfusion imaging and DE-MRI within 7 days. 99Tcm-MIBI MPI was performed to identify diffuse or segmental abnormal perfusion patterns including reduced or defect perfusion segments. DE-MRI images were divided into 4 categories: no delayed enhancement, septal, subendocardial and transmural delayed enhancement, x2 test was used for data analysis. Results Diffuse and segmental perfusion abnormality on 99Tcm-MIBI MPI were found in 19 (47.5%) and 21 (52.5%)patients respectively, while DE-MRI enhancement was simultaneously found in 5 patients of the former (5/19, 26.3%) and 18 (18/21, 85.7%) of the latter (x2 =14.401, P<0. 001). For those (n=18) with both segmental perfusion abnormality and DE-MRI enhancement, the number of segments of the 4 DE-MRI respectively. A significant difference was found in the DE-MRI enhancement categories between normal and defect perfusion segments (x2 = 29. 183, P <0.001 ) and between reduced and defect perfusion segments as well (x2 =25. 110, P<0. 001). Conclusions Both diffuse and segmental perfusion abnormalities on 99Tcm-MIBI MPI can be found in patients with IDCM. DE-MRI enhancement is more frequently found in patients with segmental perfusion abnormality.
    • 娄樱; 蒋锦琪; 袁方; 谢文晖; 张鹏; 樊济海
    • 摘要: 目的 观察扩张型心肌病患者的双嘧达莫负荷心肌201Tl SPECT显像表现.方法 2008年8月至2009年12月临床符合扩张型心肌病诊断标准的住院患者30例,按体质量0.56 mg/kg给予其双嘧达莫,于4 min内静脉注射,2 min后注射201Tl,注射完后10及240 min分别进行双嘧达莫负荷心肌201Tl SPECT显像,图像经三维重建后由2位以上有经验的核医学科医师进行分析.结果 27例(90.00%)患者的双嘧达莫负荷201Tl图像(10 min)显示左心室心肌放射性分布异常.延迟(240 min)显像时所有患者均出现左室心肌放射性分布异常,其中6例患者出现"反向再分布".结论 双嘧达莫负荷心肌201Tl SPECT显像对指导扩张型心肌病的诊治具有一定的临床意义.%Objective To explore the characteristics of dipyridamole 201 Tl myocardial perfusion imaging (MPI) SPECT in patients with dilated cardiomyopathy. Methods Thirty patients with dilated cardiomyopathy underwent pharmacological stress 201Tl MPI SPECT after intravenous infusion of dipyridamole (0. 56 mg/kg) for 4 min. The early and delayed SPECT images were acquired respectively at 10 and 240 min after 201Tl injection. The images were analyzed and reported by two or three experienced nuclear medicine physicians. Results All patients were found to have abnormal perfusion patterns at delay imaging, however 90.00% (27/30) were also abnormal at early images. Six patients had reverse redistribution. Conclusion Dipyridamole 201Tl MPI SPECT imaging may be of some value for the assessment of patients with dilated cardiomyopathy.
    • 邢晓春; 罗芝宽; 何峰; 张寰
    • 摘要: 目的 探讨曲美他嗪对扩张型心肌病患者心功能及心率变异性(HRV)的影响.方法 将60例扩张型心肌病患者随机分为A、B两组,A组给予常规治疗,B组在常规治疗基础上给予曲美他嗪20 mg/次、3次/d,共治疗12周.治疗前后应用超声心动图检测患者左室舒张末期内径(LVEDd)和左室射血分数(LVEF),应用24 h动态心电图检测HRV.结果 两组治疗前各项指标比较无统计学差异;治疗12周后两组LVEDd均较治疗前减小,LVEF及HRV均较治疗前升高(P<0.05或<0.01),且B组改善程度较A组显著(P<0.05).结论 曲美他嗪可以改善扩张型心肌病患者的心功能和HRV,从而改善患者的长期预后.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号